NEUROLOGY JOURNAL
Fecha de publicación: Marzo 2018
DOI: https://doi.org/10.1212/WNL.0000000000005057
Autores:
, , , , , , , , , ,Background: To determine whether high CSF levels of neurogranin (Ng) predict longitudinal decline in memory and executive function during early-stage Alzheimer disease (AD).